Member Info for surprised

https://twitter.com/surprised_trade/status/1324777154484338691

Hi skid again, you're clealry upset with your previous purchase of KMK it appeasr from your postings, and price movements today were skewed to some of the larget ftsee stocks that have seen dramatic falls of late...I seriously think some of the recent new holders thought there was a link between KMK and covid stocks from some of the comments I saw earlier lol....tomorrow should see a more balnced (i would imagine) market and at under 13p, particularly with Fridays 116,000 quid purchase at close a possible indicator more than spurious bb posting maybe ;-)

Kromek Group plc is a technology group and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT") and other advanced technologies. Using its core technology platforms, Kromek designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.
The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.
The Group's business model provides a vertically integrated technology offering to customers, from radiation detector materials to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").

10, 000 block buyer chipping away again , another block just bought

https://twitter.com/surprised_trade/status/1324660199731290112

kmk has started delivering on a delayed seven-year OEM contract worth £45m ,'' The contractS should deliver revenues worth millions of dollars in the current financial year, says Mr Basu. The same is true of another delayed contract from the 2019/20 year'
It's under valued by at least 40% to net asset value at 13p with a large established client list and new contracts expected in addition to the recent US development deal. Value gap exits in current sp

https://twitter.com/surprised_trade/status/1324777154484338691

delayed print after close, (116k) the order they appeared to be filling today (as discussed on the lse bb) .MM's were offering 13.50p, well above bid at times, for a large slice of my holding most of day..I still have them all

althoough delays due to covid etc clealry the price drop overdone, with both cenos and IC targeting 100p initially on an mcap ofaround 12m and 34p PTRO is still cheap and clealry mm's have a buyer or twosnapping up the cheap shares ..the 10,000 block buyer was evident a few mins ago..so even allowing for a delay or two the recurring revenue targets and new business contracts the current sp still appears undervalued if you knock the IC 100p target back to 70p today's price offers value at current levels...for both short and longer term jholders..if I'm selling any it aint down here ;)

yup a mixed bag, good contract and better accounting etc ..bloomin covid issues affecting the world are hard to steer through for most companies, however they have the finances with the recent fund raise at 47p and recurring revenue is good aspect covid issues a pain though....I'll read it again

glad I held them all :-)

and that last trade of 116 thosand pounds at 13.75p could well be why they were happy to pay 13.50p for many of my shares this morning and they held the price below it despite the buying pressure, as per my earlier post re dummy sell......the games of aim eh :-)

spell error correction.......
..... looking forward and being in position ahead of any gap up to higher value imo is the key :-)

thanks skid, different opinions are what makes a market and your critera is what you need, others have alternative views and there is always a price point where a share is providing a value gap.....I can see the potential imo ahead and rather than wait for confirmation and amuch increased sp I think there is enough info to suggest this a a good entry level for what awaits ahead, and your comments below support that view indirectly as IC couldsee further advances from 20p+ into the 30p+ level. Mistakes were made and with a new outlook, improved tech, the delayed contracts now starting to be serviced, the huge value of those contracts and recent new collaborations/contracts with new customers all the ingredients are there to further push the sp much higher, looking forward and being in position ahead of any gap up ito higher value mo is the key :-)

https://www.youtube.com/watch?v=Uazs0_gdEBo

Kromek Biological Threat Detection System

for clarity, I did not sell anything, 13p is the starting point not the end price imo with the contracts upcoming etc :-)

I think the fact the mm's were happy to take well over 10 thousand quids worth off me this morning at 13.50p (dummy test price) provides a clue, as they have not let the sp rise above it yet despite the pressure :-)

Investors Chronicle spotted the decline in sp too.....here's part of the article I've dug up
KMK - Rebound is on the cards
Firstly, Kromek has now started delivering on a delayed seven-year Original Equipment Manufacturer (OEM) contract worth US$58m (£45m) to provide its cutting edge CZT detectors and advanced electronics in state-of-the-art medical imaging detectors. The contract should deliver revenues worth “millions of dollars” in the current financial year, says Mr Basu. The same is true of another delayed contract from the 2019/20 financial year.

Secondly, the company continues to win new contracts in other parts of the business. Kromek was awarded $1.1m worth of contracts to add technical innovation capability to its D3S ‘dirty bomb detectors’ by US government agencies. They are proving popular in Europe, too, with the European Commission and Irish Civil Defence also using them. Given the heightened terrorism risk across the world, the 22 countries currently deploying the technology is likely to grow.

Thirdly, Mr Basu reassuringly notes that Kromek’s revenue is now back to pre-Covid-19 levels following the disruption of the first quarter to 31 July 2020. That’s important as it means that concerns over the company’s cash position should now ease, another reason for the share price fall since May. Finance director Derek Bulmer says that the company had gross cash of £9.4m at 30 April 2020 and gross debt of £5.6m. Since then it has strengthened its gross cash reserves by over £2m and varied bank covenants on its HSBC facility. Given that revenue has returned to pre-Covid-19 levels, and stocks are now being delivered on delayed contracts, the company should have the funding in place to operate without the need to tap shareholders. This may not have been made clear to investors.

The bottom line is that the 40 per cent share price discount to net asset value of 13p should reverse when investors cotton onto the huge commercial opportunities for Kromek's ground breaking DARPA airborne pathogens technology that is being piloted. Buy.

and a recovery stock such as this with a far below value sp provides opportunity for those who can take advantage of the current under valued sp :-)

nice momentum building, Hi skid, just using the quote from Investors chronicle, looks like the sp is rallying back, was only a few weeks ago it was over 20p, new management and a fresh look at the business suggests a value gap here and some potentially lucrative contracts in the pipeline too.....I think most new investors are looking forward here, the mistakes of the past are just that, and stock and shares is typically a forward look, of which there is much to look forward too with KMK's tech ..gla

https://twitter.com/surprised_trade/status/1324627289993302017

it's under valued by at least 40% to net asset value at 13p with a large established client list and new contracts expected in addition to the recent US development deal. A value gap exits in current sp

and to support the position patience approach I see all the other stocks you mention have made good gains back as markets pick up, as should be the case here with PTRO, a decent rise from the 30's a few weeks ago a bit of consolidation before we generate a bit more intterest ahead of next news and clealry the current under valued nature of the company at it's current price of 40p,,with cenkos and Investors chronicle both suggesting value nearer 100p+ a bit of patience and stake building here on any dips should provide decent rewards in the next few weeks and months ahead :-)

here's a clue, there are a few others too ....Kromek has now started delivering an (OEM) contract worth £45m to provide state-of-the-art medical imaging detectors. KMK revenue is now back to pre-Covid-19 levels, the 40 per cent share price discount to nav of 13p should reverse with their huge commercial opportunities.......

Kromek wins new sector-leading global OEM customer

https://www.lse.co.uk/rns/KMK/kromek-wins-new-sector-leading-global-oem-customer-z8okw49sevw0s0a.html